Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | Erlotinib | HCID 176870 | — |
| Reactant | Ether hydrochloride | HCID 10953452 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | Erlotinib Hydrochloride | HCID 176871 | 0.24% |
Reaction Steps
Erlotinib free base (5 gm, obtained in step-II) is dissolved in chloroform (200 ml) at 25-30° C. to form a clear solution and then is added diethyl ether (50 ml). To the resulting solution is slowly added 15% diethyl ether HCl (5 ml) at 25-30° C. and stirred for 30 minutes at 25-30° C. The material, is filtered washed with a mixture of diethyl ether (10 ml) and chloroform (10 ml), and then dried at 60-65° C. under vacuum to give 4.9 gm of erlotinib hydrochloride [HPLC purity: 99.7%; Content of N-methoxyethyl impurity: 0.24% (at 1.14 RRT)].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08389531B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-ec2cd3bd12e046cc9f89eac6eb2d3198 |
|---|
| Source note | uspto-grants-2013_03 |
|---|